Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 8;21 translocation in leukemogenesis.

Luke F Peterson1, Dong-Er Zhang

  • 11Department of Molecular and Experimental Medicine, The Scripps Research Institute, Mail Drop: MEM-L51, La Jolla, CA 92037, USA.

Oncogene
|May 25, 2004
PubMed
Summary

The AML1-ETO fusion protein, resulting from the t(8;21) chromosomal translocation, is a key factor in acute myeloid leukemia (AML) development. This review explores its structure and in vitro functions to understand its leukemogenic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell therapy manufacturing at full clinical scale: enhancing the quality CAR-T cell therapy starting materials through massively parallel automated microfluidic cell sorting.

Lab on a chip·2026
Same author

Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX models.

Leukemia·2026
Same author

Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction.

Nature communications·2026
Same author

Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction.

bioRxiv : the preprint server for biology·2025
Same author

Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML.

Blood neoplasia·2025
Same author

ISG15 Drives Immune Pathology and Respiratory Failure during Systemic Lymphocytic Choriomeningitis Virus Infection.

Journal of immunology (Baltimore, Md. : 1950)·2024

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • The t(8;21) chromosomal translocation is a frequent genetic alteration in AML, observed in approximately 12% of de novo cases.
  • This translocation results in the formation of the AML1-ETO fusion protein, a critical oncogenic driver.

Purpose of the Study:

  • To review the structural characteristics of the AML1-ETO fusion protein.
  • To summarize in vitro findings regarding the functional impact of AML1-ETO.
  • To elucidate the potential mechanisms underlying the leukemogenic activity of AML1-ETO.

Main Methods:

  • Literature review of studies investigating AML1-ETO.
  • Analysis of structural data related to the fusion protein.
  • Synthesis of in vitro experimental findings on AML1-ETO function.

Main Results:

  • The AML1-ETO fusion protein results from the joining of the AML1 gene on chromosome 21 and the ETO gene on chromosome 8.
  • t(8;21) is prevalent in AML subtypes M2, M0, M1, and M4.
  • In vitro studies provide insights into the aberrant functions of AML1-ETO, but its precise role in leukemogenesis remains incompletely understood.

Conclusions:

  • The AML1-ETO fusion protein is a significant contributor to AML pathogenesis.
  • Further research into the structural and functional aspects of AML1-ETO is crucial for understanding its leukemogenic potential.
  • Elucidating these mechanisms may reveal novel therapeutic targets for AML.

Related Experiment Videos